August 21-23, 2018
Boston, MA

Only 1 more week to go!
Secure Your Place Today


Mimetas: Program Partner

MIMETAS, a Leiden-based microfluidics company founded in 2013, develops Organ-on-a-Chip technology for high‐throughput testing of new medicines in more predictive miniaturized organ models. MIMETAS is world-leading in passive microfluidics and has a unique OrganoPlate® technology based on a proprietary microfluidic liquid handling technique called PhaseGuides™, enabling membrane-free in vitro 3D co-culture models with continuous perfusion for a large variety of tissues and diseases. The OrganoPlate® design, based on a microtiter plate, is compatible with standard robot and readout equipment.